Literature DB >> 11715299

[Definition of volumes in external radiotherapy: ICRU reports 50 and 62].

J Chavaudra1, A Bridier.   

Abstract

Prescribing and achieving radiotherapy require accurate definitions of the target volumes and of the dose to be delivered in them. The need for the availability of a coherent vocabulary, recognized from local to international levels, has justified the publication, by the ICRU, of two reports related to external radiotherapy, the Report 50 (1993) and the Report 62 (1999). This paper presents the main propositions of the ICRU for the definition of the volumes, as well as comments and recommendations for their use.

Mesh:

Year:  2001        PMID: 11715299     DOI: 10.1016/s1278-3218(01)00117-2

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  18 in total

Review 1.  Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Uğur Selek; Yasemin Bölükbaşı; James W Welsh; Erkan Topkan
Journal:  Balkan Med J       Date:  2014-09-13       Impact factor: 2.021

Review 2.  The future of image-guided radiotherapy will be MR guided.

Authors:  Julianne M Pollard; Zhifei Wen; Ramaswamy Sadagopan; Jihong Wang; Geoffrey S Ibbott
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

3.  Evaluation of dose distribution differences from five algorithms implemented in three commercial treatment planning systems for lung SBRT.

Authors:  Vikren Sarkar; Adam Paxton; Prema Rassiah; Kristine E Kokeny; Ying J Hitchcock; Bill J Salter
Journal:  J Radiosurg SBRT       Date:  2020

Review 4.  Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.

Authors:  Tejan P Diwanji; Pranshu Mohindra; Melissa Vyfhuis; James W Snider; Chaitanya Kalavagunta; Sina Mossahebi; Jen Yu; Steven Feigenberg; Shahed N Badiyan
Journal:  Transl Lung Cancer Res       Date:  2017-04

5.  Parotid Gland Stem Cell Preservation during Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Dosimetric Analysis and Feasibility.

Authors:  Lirong Zheng; Qiaoli Mei; Yuxiang Gao; Fenglei Du; Lin Xiao; Gangfeng Wu
Journal:  J Oncol       Date:  2022-07-12       Impact factor: 4.501

6.  Dosimetric impact of baseline drift in volumetric modulated arc therapy with breath holding.

Authors:  Shunsuke Ono; Yoshihiro Ueda; Shoki Inui; Masaru Isono; Shingo Ohira; Seiya Murata; Masayoshi Miyazaki; Teruki Teshima
Journal:  Rep Pract Oncol Radiother       Date:  2020-06-08

7.  Characterization of positioning uncertainties in PET-CT-MR trimodality solutions for radiotherapy.

Authors:  Pauline Hinault; Isabelle Gardin; Pierrick Gouel; Pierre Decazes; Sebastien Thureau; Ovidiu Veresezan; Henri Souchay; Pierre Vera; David Gensanne
Journal:  J Appl Clin Med Phys       Date:  2022-04-28       Impact factor: 2.243

8.  Dosimetric impact on changes in target volumes during intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  Wafa Mnejja; Hend Daoud; Nejla Fourati; Tarek Sahnoun; Wicem Siala; Leila Farhat; Jamel Daoud
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-16

9.  Evaluation of high-grade astrocytoma recurrence patterns after radiotherapy in the era of temozolomide: A single institution experience.

Authors:  Arno Lotar Cordova; Taynná Vernalha Rocha Almeida; Cintia Mara da Silva; Pedro Argolo Piedade; Cristiane Maria Almeida; Carlos Genesio Bezzera Lima; Carolina Dutra; Rafael Martins Ferreira; Marcelo Neves Linhares; Valeriy Denyak
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-17

10.  Does obesity hinder radiotherapy in endometrial cancer patients? The implementation of new techniques in adjuvant radiotherapy - focus on obese patients.

Authors:  Małgorzata Moszyńska-Zielińska; Justyna Chałubińska-Fendler; Leszek Gottwald; Leszek Żytko; Ewelina Bigos; Jacek Fijuth
Journal:  Prz Menopauzalny       Date:  2014-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.